Mirae Asset Global Etfs Holdings Ltd. Immunovant, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immunovant, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 40,971 shares of IMVT stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,971
Previous 37,623
8.9%
Holding current value
$1.13 Million
Previous $1.04 Million
8.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMVT
# of Institutions
226Shares Held
78.4MCall Options Held
1.5MPut Options Held
1.55M-
Deep Track Capital, LP Greenwich, CT9.5MShares$261 Million9.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.94MShares$191 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.89MShares$162 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY5.46MShares$150 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.92MShares$135 Million0.0% of portfolio
About Immunovant, Inc.
- Ticker IMVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,077,000
- Market Cap $3.55B
- Description
- Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...